- Home
- HBNC vs CINGW Comparison
HBNC vs CINGW Comparison
Compare HBNC & CINGW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HBNC
- CINGW
- Stock Information
- Founded
- HBNC 1873
- CINGW N/A
- Country
- HBNC United States
- CINGW United States
- Employees
- HBNC N/A
- CINGW 13
- Industry
- HBNC Major Banks
- CINGW Biotechnology: Pharmaceutical Preparations
- Sector
- HBNC Finance
- CINGW Health Care
- Exchange
- HBNC Nasdaq
- CINGW Nasdaq
- Market Cap
- HBNC 648.7M
- CINGW N/A
- IPO Year
- HBNC N/A
- CINGW 2021
- Fundamental
- Price
- HBNC $15.23
- CINGW $0.06
- Analyst Decision
- HBNC Hold
- CINGW
- Analyst Count
- HBNC 3
- CINGW 0
- Target Price
- HBNC $15.33
- CINGW N/A
- AVG Volume (30 Days)
- HBNC 174.8K
- CINGW N/A
- Earning Date
- HBNC 10-23-2024
- CINGW N/A
- Dividend Yield
- HBNC 4.20%
- CINGW N/A
- EPS Growth
- HBNC N/A
- CINGW N/A
- EPS
- HBNC 0.43
- CINGW N/A
- Revenue
- HBNC $179,998,000.00
- CINGW N/A
- Revenue This Year
- HBNC N/A
- CINGW N/A
- Revenue Next Year
- HBNC $7.84
- CINGW N/A
- P/E Ratio
- HBNC $35.26
- CINGW N/A
- Revenue Growth
- HBNC N/A
- CINGW N/A
- 52 Week Low
- HBNC $9.22
- CINGW N/A
- 52 Week High
- HBNC $16.64
- CINGW N/A
- Technical
- Relative Strength Index (RSI)
- HBNC 51.42
- CINGW N/A
- Support Level
- HBNC $14.44
- CINGW N/A
- Resistance Level
- HBNC $14.83
- CINGW N/A
- Average True Range (ATR)
- HBNC 0.38
- CINGW 0.00
- MACD
- HBNC -0.05
- CINGW 0.00
- Stochastic Oscillator
- HBNC 57.25
- CINGW 0.00
About HBNC Horizon Bancorp Inc.
Horizon Bancorp (IN) is a United States-based holding company providing banking services. It is engaged in providing commercial and retail banking services, corporate and individual trust and agency services, and other services incident to banking. The company also provides commercial loans, real estate loans, mortgage warehouse loans, consumer loans, and other credit facilities. The company has one principal business segment, commercial banking.
About CINGW Cingulate Inc.
Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic areas to use PTR technology to develop future product candidates.